Tevogen Bio Holdings Inc. Common Stock

TVGNNASDAQ • USD
ThemeHealthcare - Oncology›Cell & Gene Therapy for Cancer
4.21 USD
↘ 0.20 (4.54%)AT CLOSE (11:59 AM EDT)
4.18
↘ 0.03 (0.71%)
POST MARKET (AS OF 04:04 PM EDT)
Post Market
AS OF 04:04 PM EDT
4.18
↘ 0.03 (0.71%)
🟢Market: OPEN

Shares of Tevogen Bio Holdings Inc. Common Stock (TVGN) are trading at $4.79. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (224.3%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.

Technical & fundamental data as of Jul 17, 2026.

Open?$4.34
High?$4.37
Low?$4.15
Prev. Close?$4.41
Volume?8.8K
Avg. Volume?24.9K
VWAP?$4.25
Rel. Volume?0.35x
Bid / Ask
Bid?$3.54 × 100
Ask?$5.73 × 100
Spread?$2.19
Midpoint?$4.64
Valuation & Ratios
Market Cap?18.6M
Shares Out?4.2M
Float?909.9K
Float %?21.7%
P/E Ratio?N/A
P/B Ratio?-1.89
EPS?-$5.23
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.
Themes
Healthcare - Oncology›Cell & Gene Therapy for CancerBiotech - Drug Development›Infectious Disease & VaccinesHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
18
Market Cap
18.6M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.tevogen.com
Listed
2024-02-15
Address
15 INDEPENDENCE BOULEVARD, SUITE #210
WARREN, NJ 07059
Phone: 646-807-8832
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
76
Piotroski F-Score?0/9Weak
Altman Z-Score?-55.98Distress
Confidence?41%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?7.19%Elevated
Short Interest?65.4K
Days to Cover?2.5
Free Float909.9K
Avg Daily Volume26.4K
Settlement Date2026-06-30
Financial Health
Current Ratio?0.29Weak
Quick Ratio?0.29Weak
Cash Ratio?0.10Low
Debt/Equity?-0.82Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-1.89CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.3CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
224.3%STRONG▾
ROA?
S&P
3
-448.7%WEAK▾
Cash Flow & Enterprise
FCF?$-11818722
Enterprise Value?$26.0M
Fundamentals ratios updated end of day
MarketsMoversWatchlist